Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study.

BACKGROUND: The severe acute respiratory syndrome Coronarovirus-2 associated still causes a significant number of deaths and hospitalizations mainly by the development of respiratory failure. We aim to validate lung ultrasound score in order to predict mortality and the severity of the clinical course related to the need of respiratory support. METHODS: In this prospective multicenter hospital-based cohort study, all adult patients with diagnosis of SARS-CoV-2 infection, performed by real-time reverse transcription polymerase chain reaction were included. Upon admission, all patients underwent blood gas analysis and lung ultrasound by expert operators. The acquisition of ultrasound scan was performed on 12 peculiar anatomic landmarks of the chest. Lung ultrasound findings were classified according to a scoring method, ranging 0 to 3: Score 0: normal A-lines. Score 1: multiple separated B-lines. Score 2: coalescent B-lines, alteration of pleural line. Score 3: consolidation area. RESULTS: One thousand and seven patients were included in statistical analysis (male 62.4 %, mean age 66.3). Oxygen support was needed in 811 (80.5 %) patients. The median ultrasound score was 24 and the risk of having more invasive respiratory support increased in relation to higher values score computed. Lung ultrasound score showed negative strong correlation (rho: -0.71) with the P/F ratio and a significant association with in-hospital mortality (OR 1.11, 95 %CI 1.07-1.14; p < 0.001), even after adjustment with the following variables (age, sex, P/F ratio, SpO2, lactate, hypertension, chronic renal failure, diabetes, and obesity). CONCLUSIONS: The novelty of this research corroborates and validates the 12-field lung ultrasound score as tool for predicting mortality and severity clinical course in COVID-19 patients. Baseline lung ultrasound score was associated with in-hospital mortality and requirement of intensive respiratory support and predict the risk of IOT among COVID-19 patients.

Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2.

BACKGROUND: During the COVID-19 outbreak, a very high number of infected patients developed pneumonia and many of them complicated with acute respiratory distress syndrome. The optimal management of respiratory failure and the role of lung ultrasound imaging in the evaluation of efficacy of treatment are unknown. METHODS: In March 2020 we treated 18 patients with mild and moderate ARDS secondary to SARS-CoV-2 with non-invasive continuous positive airway pressure therapy (NI-CPAP). All patients underwent lung ultrasound imaging to verify the entity of lung recruitment after NI-CPAP initiation. RESULTS: After one hour of treatment we observed a significant improvement in PaO2/FiO2 ratio in 10 patients. Notably, only 50 % of them reached an effective improvement in lung aeration detectable with lung ultrasound. In the other 50 % or patients the improvement in PaO2/FiO2 might be related to blood redistribution and reverse of hypoxic vasoconstriction. CONCLUSION: NI- CPAP is a valid therapeutic option in mild and moderate ARDS secondary SARS-CoV-2. Lung recruitment detected by means of lung ultrasound is a relevant but not the exclusive mechanism that underlies the therapeutic efficacy of NI-CPAP in this clinical setting.

Two-year follow-up after microsurgical discectomy and dynamic percutaneous stabilization in degenerate and herniated lumbar disc: clinical and neuroradiological outcome.

AIM: Lumbar disc herniation associated with back pain is often related to disc degeneration. Back pain after microdiscectomy often persists, prejudicing clinical outcome and quality of life. To this day, the evolution of disc degeneration after classical microdiscectomy has never been proven. Percutaneous dynamic stabilization after microdiscectomy has been proposed as a novel surgical strategy for treatment of back pain with herniated disc. However, clinical results are still debated and no evidences about the long-term evolution of back pain and relationships between neuroradiological imaging and clinical outcome have been provided. We report our preliminary observations concerning the clinical and neuroradiological outcome of 11 patients treated with microdiscectomy and dynamic percutaneous lumbo-sacral stabilization, after a long-term follow-up (2-years). METHODS: This was an uncontrolled case series. The study included 11 patients (3 F, 8 M) with L5-S1 discal herniation and degeneration underwent microdiscectomy and percutaneous dynamic stabilization, from December 2008 to November 2009. All the patients were symptomatic with back and leg pain non-responsive to long-term (8-12 months) medical and physical treatments. VAS and Satisfaction Index were used, respectively, for evaluation of clinical outcome and general postoperative patients' satisfaction. Modic and Pfirrmann scores were used for evaluation of neuroradiological outcome. All the patients underwent to microdiscectomy and implantation of the same percutaneous device for dynamic stabilization of the middle vertebral column during the same surgery. Modic, Pfirrmann, VAS and Satisfaction Index scores were collected before surgery and over the follow-up (45 days, 1 and 2 years). MRI and dynamic X-Ray 2 years after surgery were compared to the preoperative imaging. RESULTS: Motion preservation at the functional spinal unit after surgery was demonstrated in all the cases. All patients reported a reduction or complete resolution of back and leg pain, they were satisfied and came back to normal socio-professional life. No modification of the preoperative Pfirrmann was observed, even in those patients who experienced restoration of back pain. No surgical complications nor device failures were reported. CONCLUSION: Percutaneous minimally invasive lumbo-sacral dynamic stabilization after microdiscectomy seems a reliable and effective technique in order to obtain a resolution of back pain and seems to prevent the Pfirrmann worsening, over a long-term follow-up.